查询: 取消
免责声明:证券数据为本网搜集归纳,尽量保证及时准确,入市投资请以上市公司公布的正式公告为准。本网证券行情存在延时,交易请以交易所即时行情价格为准。所有数据仅供参考,据此入市风险自担。
南模生物(688265)研究和试验发展
上涨家数:27下跌家数:3平均涨幅:+2.74%
更新时间:2025-09-05 15:00
名称最新价(元)市盈率(倍)涨跌幅
昭衍新药34.0183.69+9.99%
泰格医药66.58193.91+6.66%
普蕊斯49.2036.79+5.81%
康龙化成31.3040.29+5.56%
药明康德107.4023.02+5.36%
诺思格58.0239.23+4.94%
美迪西67.40-33.11+4.69%
奥浦迈52.96174.50+3.92%
药石科技44.2150.39+3.85%
毕得医药65.0042.50+3.75%
泓博医药37.89204.46+3.21%
和元生物7.75-16.07+3.20%
皓元医药69.9052.40+3.13%
阳光诺和77.1154.43+3.06%
百诚医药62.87-37.35+2.86%
药康生物17.6469.28+2.56%
泰坦科技24.92233.36+2.21%
益诺思40.02152.70+2.01%
近岸蛋白43.18-43.45+1.79%
诺唯赞23.19-296.35+1.76%
中源协和25.25162.00+1.69%
阿拉丁13.0154.12+1.64%
博济医药10.82293.54+1.60%
万邦医药43.7550.89+1.41%
义翘神州81.3983.42+1.34%
南模生物55.89128.89+1.34%
睿智医药13.18-47.50+0.08%
百花医药10.8694.27-1.90%
成都先导27.06118.88-2.31%
百普赛斯58.6465.21-2.91%

转至南模生物(688265)行情首页

中财网版权所有(C) HTTP://WWW.CFi.CN